Epigenetic Tumor Markers in Plasma and Serum
- 25 January 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 945 (1), 36-50
- https://doi.org/10.1111/j.1749-6632.2001.tb03862.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Tumor‐Derived Epigenetic Changes in the Plasma and Serum of Liver Cancer Patients: Implications for Cancer Detection and MonitoringAnnals of the New York Academy of Sciences, 2000
- Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implicationsBlood, 2000
- Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosisProceedings of the National Academy of Sciences, 1998
- K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancerGastroenterology, 1997
- Microsatellite alterations in plasma DNA of small cell lung cancer patientsNature Medicine, 1996
- Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignanciesBlood, 1996
- Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhoodBlood, 1995
- Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemiaBritish Journal of Haematology, 1994
- Functional interactions of the retinoblastoma protein with mammalian D-type cyclinsCell, 1993